Brief: Conduit Pharmaceuticals Partners With Charles River In Systemic Lupus Erythematosus Model

CDT Equity

13/02/2025 13:07

Feb 13 (Reuters) - Conduit Pharmaceuticals  CDT.O :
    * CONDUIT PHARMACEUTICALS INC: PARTNERS WITH CHARLES RIVER
IN
CLINICALLY RELEVANT SYSTEMIC LUPUS ERYTHEMATOSUS MODEL
    * CONDUIT PHARMACEUTICALS: STUDY TO ACCELERATE DEVELOPMENT
OF
AZD1656 FOR AUTOIMMUNE DISORDERS, FOCUS ON SYSTEMIC LUPUS
ERYTHEMATOSUS, LUPUS NEPHRITIS

Source text:  ID:nGNX6dgWCT 
Further company coverage:  CDT.O 

 ((Reuters.Briefs@thomsonreuters.com;))